Lansoprazole
Product Images NDC 16590-891

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 16590-891). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lansoprazole Dr 15mg Label 890)

Label Image (Lansoprazole Dr 15mg Label 890)
This is a medication package containing Lansoprazole 15mg Delayed-Release capsules distributed by Sandoz Inc. The package was packaged and distributed from Gainesville, GA with a batch code of DC 1659089030. The manufacturer's product code is NOC 0781-2353-31 and the sample is labeled MD 1111712011.*
FDA Label Image

Label Image (Lansoprazole Dr 30mg Label 891)

Label Image (Lansoprazole Dr 30mg Label 891)
This is a description of Lansoprazole capsules. The capsules are packaged and produced by Sandoz Inc in Princeton, NJ. They are delayed-release capsules containing 30mg of Lansoprazole. The lot number for the capsules is A235588 and the expiration date is 07/14 MD 11/17/2011. The NDC number is 16590-891-30.*
FDA Label Image

Chemical Structure (Lansoprazole 01)

FDA Label Image

Figure (Lansoprazole 02)

Figure (Lansoprazole 02)
This is a graph showing the mean severity of day heartburn for evaluable patients over the course of treatment with a placebo, 15 mg Lansoprazole, and 30 mg Lansoprazole. The severity is rated on a scale of 1 to 3, with 3 being severe and 1 being mild. The x-axis shows the days from the start of treatment.*
FDA Label Image

Figure (Lansoprazole 03)

Figure (Lansoprazole 03)
The text describes a graph showing the mean severity of night heartburn for evaluable patients over the days from the start of the treatment. The severity is measured on a scale from none to severe. However, there is no image of the graph available to analyze.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.